ArticleCell cycle (Georgetown, Tex.)2013

Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Ekaterina Lesovaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.